Trial Outcomes & Findings for A Randomized Placebo-Controlled Trial of Manuka Honey for Oral Mucositis Due to Radiation Therapy for Cancer (NCT NCT00615420)

NCT ID: NCT00615420

Last Updated: 2019-06-05

Results Overview

Worst Radiation Therapy Oncology Group (RTOG) score greater than or equal to Grade 3 mucositis The scale ranges from Grade 0 (No mucositis) to Grade 4 (Necrosis or deep ulceration ± bleeding) where Grade 0 is the best outcome and Grade 4 is the worst outcome.

Recruitment status

COMPLETED

Study phase

PHASE3

Target enrollment

106 participants

Primary outcome timeframe

Over 7 weeks of expected duration of mucositis

Results posted on

2019-06-05

Participant Flow

Participant milestones

Participant milestones
Measure
Honey
Irradiated organic manuka honey 5ml 4 times a day held in mouth for 30 secs then swallowed manuka honey: Irradiated organic manuka honey 5ml 4 times a day held in mouth for 30 secs then swallowed. May be diluted with equal or twice the volume of water to reduce nausea in patients already nauseated from chemotherapy.
Placebo
Sugar-free placebo gel 5ml 4 times a day, swished and held in mouth for 30 secs then swallowed placebo gel: Sugar-free honey-flavoured gel 5ml 4 times a day swished and held in mouth for 30 secs then swallowed. May be diluted with equal or twice the volume of water to reduce nausea in patients already nauseated from chemotherapy.
Overall Study
STARTED
54
52
Overall Study
COMPLETED
23
25
Overall Study
NOT COMPLETED
31
27

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Not all patients have baseline information available

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Honey
n=54 Participants
Irradiated organic manuka honey 5ml 4 times a day held in mouth for 30 secs then swallowed manuka honey: Irradiated organic manuka honey 5ml 4 times a day held in mouth for 30 secs then swallowed. May be diluted with equal or twice the volume of water to reduce nausea in patients already nauseated from chemotherapy.
Placebo
n=52 Participants
Sugar-free placebo gel 5ml 4 times a day, swished and held in mouth for 30 secs then swallowed placebo gel: Sugar-free honey-flavoured gel 5ml 4 times a day swished and held in mouth for 30 secs then swallowed. May be diluted with equal or twice the volume of water to reduce nausea in patients already nauseated from chemotherapy.
Total
n=106 Participants
Total of all reporting groups
Age, Continuous
56.8 years
n=52 Participants • Not all patients have baseline information available
59.5 years
n=48 Participants • Not all patients have baseline information available
58.1 years
n=100 Participants • Not all patients have baseline information available
Sex: Female, Male
Female
10 Participants
n=54 Participants • Not all patients have baseline information available
8 Participants
n=50 Participants • Not all patients have baseline information available
18 Participants
n=104 Participants • Not all patients have baseline information available
Sex: Female, Male
Male
44 Participants
n=54 Participants • Not all patients have baseline information available
42 Participants
n=50 Participants • Not all patients have baseline information available
86 Participants
n=104 Participants • Not all patients have baseline information available
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Weight
85.6 kg
STANDARD_DEVIATION 19.3 • n=52 Participants • Not all patients have baseline information available
79.6 kg
STANDARD_DEVIATION 15.2 • n=50 Participants • Not all patients have baseline information available
82.7 kg
STANDARD_DEVIATION 17.6 • n=102 Participants • Not all patients have baseline information available
Diabetic
3 Participants
n=54 Participants
10 Participants
n=52 Participants
13 Participants
n=106 Participants
Smoker
9 Participants
n=54 Participants
7 Participants
n=52 Participants
16 Participants
n=106 Participants
ECOG > 0
8 Participants
n=54 Participants
13 Participants
n=52 Participants
21 Participants
n=106 Participants
Chemotherapy
31 Participants
n=54 Participants
35 Participants
n=52 Participants
66 Participants
n=106 Participants
Radiation Therapy => 7,000 Gy
36 Participants
n=54 Participants
30 Participants
n=52 Participants
66 Participants
n=106 Participants

PRIMARY outcome

Timeframe: Over 7 weeks of expected duration of mucositis

Population: Patients who had at least one mucositis assessment were included in this analysis

Worst Radiation Therapy Oncology Group (RTOG) score greater than or equal to Grade 3 mucositis The scale ranges from Grade 0 (No mucositis) to Grade 4 (Necrosis or deep ulceration ± bleeding) where Grade 0 is the best outcome and Grade 4 is the worst outcome.

Outcome measures

Outcome measures
Measure
Honey
n=40 Participants
Irradiated organic manuka honey 5ml 4 times a day held in mouth for 30 secs then swallowed manuka honey: Irradiated organic manuka honey 5ml 4 times a day held in mouth for 30 secs then swallowed. May be diluted with equal or twice the volume of water to reduce nausea in patients already nauseated from chemotherapy.
Placebo
n=41 Participants
Sugar-free placebo gel 5ml 4 times a day, swished and held in mouth for 30 secs then swallowed placebo gel: Sugar-free honey-flavoured gel 5ml 4 times a day swished and held in mouth for 30 secs then swallowed. May be diluted with equal or twice the volume of water to reduce nausea in patients already nauseated from chemotherapy.
Severity of Mucositis According to the Radiation Therapy Oncology Group (RTOG) for Patients Who Had at Least One Mucositis Assessment
14 Participants
18 Participants

PRIMARY outcome

Timeframe: Over 7 weeks of expected duration of mucositis

Population: Patients who had a minimum of 2 mucositis assessments were included in this analysis

Worst Radiation Therapy Oncology Group (RTOG) score greater than or equal to Grade 3 mucositis The scale ranges from Grade 0 (No mucositis) to Grade 4 (Necrosis or deep ulceration ± bleeding) where Grade 0 is the best outcome and Grade 4 is the worst outcome.

Outcome measures

Outcome measures
Measure
Honey
n=31 Participants
Irradiated organic manuka honey 5ml 4 times a day held in mouth for 30 secs then swallowed manuka honey: Irradiated organic manuka honey 5ml 4 times a day held in mouth for 30 secs then swallowed. May be diluted with equal or twice the volume of water to reduce nausea in patients already nauseated from chemotherapy.
Placebo
n=33 Participants
Sugar-free placebo gel 5ml 4 times a day, swished and held in mouth for 30 secs then swallowed placebo gel: Sugar-free honey-flavoured gel 5ml 4 times a day swished and held in mouth for 30 secs then swallowed. May be diluted with equal or twice the volume of water to reduce nausea in patients already nauseated from chemotherapy.
Severity of Mucositis According to the Radiation Therapy Oncology Group (RTOG) for Patients Who Had a Minimum of 2 Mucositis Assessments
11 Participants
16 Participants

Adverse Events

Honey

Serious events: 0 serious events
Other events: 8 other events
Deaths: 0 deaths

Placebo

Serious events: 0 serious events
Other events: 6 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Honey
n=54 participants at risk
Irradiated organic manuka honey 5ml 4 times a day held in mouth for 30 secs then swallowed manuka honey: Irradiated organic manuka honey 5ml 4 times a day held in mouth for 30 secs then swallowed. May be diluted with equal or twice the volume of water to reduce nausea in patients already nauseated from chemotherapy.
Placebo
n=52 participants at risk
Sugar-free placebo gel 5ml 4 times a day, swished and held in mouth for 30 secs then swallowed placebo gel: Sugar-free honey-flavoured gel 5ml 4 times a day swished and held in mouth for 30 secs then swallowed. May be diluted with equal or twice the volume of water to reduce nausea in patients already nauseated from chemotherapy.
Gastrointestinal disorders
Nausea
14.8%
8/54
9.6%
5/52
Product Issues
Bad Taste
0.00%
0/54
1.9%
1/52
Product Issues
Burning Sensation in Mouth
3.7%
2/54
0.00%
0/52

Additional Information

Dr. Philippa Hawley

BC Cancer

Phone: (604) 877-6000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place